Drugs / OR-101
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06045624 | Oct 2023 → Feb 2024 | alopecia areata | Ornovi, Inc. | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OR-101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06045624 ↗ |
| Route | Oral | “Route of administration- Oral” NCT06045624 ↗ |